Letters of Support from Experts re: Access to Psilocybin for Training Purposes
A collection of letters of support from healthcare professionals, researchers, and experts regarding legal access to psilocybin for healthcare professional training. The page explains the need for experiential training in psilocybin-assisted psychotherapy and the exemption process referenced by TheraPsil.
Provider
Details
Enrollment
Course Overview
This course page presents supporting statements from clinicians and researchers about allowing healthcare professionals to access psilocybin for training purposes. The source material focuses on experiential training as part of preparing practitioners to facilitate psilocybin-assisted psychotherapy. It describes TheraPsil's training context, including the need for qualified healthcare professionals who can provide safe and effective care in this modality. The page also outlines the legal framework referenced in the source, including Section 56 exemptions and the Special Access Program. The content is aimed at healthcare professionals involved in psilocybin therapy training, as well as those interested in the policy and clinical rationale for experiential learning. The page includes individual letters of support from named experts.
Who is this for?
Healthcare professionals, therapists, researchers, and clinicians interested in psilocybin-assisted psychotherapy training and access.
Prerequisites
None stated on the source page.
About the Provider
TheraPsil is a Canadian nonprofit focused on legal access to psychedelic-assisted therapy for people in medical need. Its current public work spans patient navigation, prescriber and therapist training, referrals, and sustained advocacy around federal access pathways. The organization remains one of the clearest Canadian patient-access stakeholders because it links policy work to concrete care pathways. Current materials show active work on Project Solace, ongoing clinician upskilling, and new Manitoba progress around MDMA-assisted therapy.
View TheraPsil profileCourse Details
- PricePrice on request
- Lifecycle statusDiscontinued
- SkillsIntegrationFacilitationPsychotherapyPsilocybin TherapyClinical reflection on patient experienceTherapeutic intervention judgment in psychedelic sessionsIntegration support conceptspsilocybin-assisted psychotherapy contextexperiential trainingclinical care rationalepolicy and regulatory awarenessreviewing expert support statementsUnderstanding experiential training rationaleClinical and policy interpretation
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jul 13, 2026
Accredited vs Non-Accredited Psychedelic Training
By AAA Learning Institute
Compare accredited and non-accredited psychedelic training programs, with an overview of what accreditation means and how to evaluate program quality. The page focuses on structure, practicum, curriculum, and practical considerations for prospective psilocybin facilitator students.
TheraPsil's Training Program
By TheraPsil
TheraPsil's professional training pathway prepares healthcare professionals and related practitioners for legal, ethical psychedelic-assisted care through didactic learning, live seminars, experiential components, and practicum-oriented training.
Course options
Fundamentals
Standard on-demand access
Full Programme
Standard on-demand access
Full Programme
Standard on-demand access
New Mexico Track
Standard on-demand access